ImmunityBio, Inc. Common Stock (IBRX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for IBRX. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 320 institutions reported holding IBRX, with 158.4 million shares worth $1.5 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Vanguard41,734,134$394MINCREASED
BlackRock36,123,813$341MINCREASED
State Street21,095,418$199MDECREASED
Geode Capital Management10,606,654$100MINCREASED
UBS Group3,775,302$36MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Barry J. Simon (Director)SELL25,000$269K2026-10-05
Cheryl Cohen (Director)EXERCISE55,979$167K2026-10-02
Cheryl Cohen (Director)SELL81,056$851K2026-10-02
Cheryl Cohen (Director)EXERCISE55,979$167K2026-10-02

Recent Congressional Trades

MemberTypeAmountDate
Lisa C. McClain (Republican)PURCHASE$1,001 - $15,0002026-09-30
Lisa C. McClain (Republican)PURCHASE$1,001 - $15,0002026-09-28

Full institutional holdings, insider history, and congressional trades for ImmunityBio, Inc. Common Stock on SentiSense.